期刊： VASCULAR PHARMACOLOGY, 2023; 151 ()
Pulmonary arterial hypertension (PAH) is a rare cardiopulmonary disorder, involving the remodelling of the small pulmonary arteries. Underlying this r......
期刊： VASCULAR PHARMACOLOGY, 2023; 153 ()
The term coronary microvascular dysfunction (CMD) encompasses several pathogenetic mechanisms resulting in functional and/or structural changes in the......
期刊： VASCULAR PHARMACOLOGY, 2023; 148 ()
Advanced heart failure (HF) is associated with a very poor prognosis and places a big burden on health-care services. The gold standard treatment, i.e......
期刊： VASCULAR PHARMACOLOGY, 2023; 150 ()
Background and purpose: Pregnancy-associated vascular remodelling is essential for both maternal and fetal health. We have previously shown that mater......
期刊： VASCULAR PHARMACOLOGY, 2023; 152 ()
Vascular endothelial and smooth muscle cell dysfunction proceed the development of numerous vascular diseases, such as atherosclerosis. Both estrogen ......
期刊： VASCULAR PHARMACOLOGY, 2023; 153 ()
Hypertension represents a major contributor to the development of coronary artery disease. The pathophysiological mechanisms underlying the link betwe......
期刊： VASCULAR PHARMACOLOGY, 2023; 152 ()
Aging is one of the most promising risk factors for vascular diseases, however, the precise mechanisms mediating aging-related pathologies are not ful......
期刊： VASCULAR PHARMACOLOGY, 2023; 153 ()
Inflammation and hyperlipidemia act synergistically to drive atherosclerotic progression. Multiple randomized trials now demonstrate that lower is bet......
期刊： VASCULAR PHARMACOLOGY, 2023; 150 ()
Aims: The prevalence of left ventricular (LV) diastolic and vascular dysfunction increases with age, eventually leading to heart failure with preserve......
期刊： VASCULAR PHARMACOLOGY, 2023; 151 ()
Pulmonary hypertension due to left heart disease (PH-LHD) or group 2 PH is the most common and lethal form of PH, occurring secondary to left ventricu......
期刊： VASCULAR PHARMACOLOGY, 2023; 152 ()
Background: Cardiotoxicity restricts anthracycline and trastuzumab treatment of Human Epidermal Growth Factor Receptor 2 positive early breast cancer.......
期刊： VASCULAR PHARMACOLOGY, 2023; 153 ()
Gottingen Minipigs (GM) are used as an important preclinical model for cardiovascular safety pharmacology and for evaluation of cardiovascular drug ta......
期刊： VASCULAR PHARMACOLOGY, 2023; 152 ()
Aims: Myocardial ischemia and infarction are the number one cause of cardiovascular disease associated mortality. Cardiomyocyte death during ischemia ......
期刊： VASCULAR PHARMACOLOGY, 2023; 149 ()
Opioids are widely being used for chronic pain management, cough and diarrhea suppressants, anesthetic agents, and opioid de-addiction therapy. Opioid......
